Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: IMO, re-validated 148, is a catch all for the other dys1

The examiner's rationale for rejecting those new claims is not unfounded. There is a sound basis, which makes fighting it a bit more problematic. And if little or nothing is lost by foregoing those additional claims, why prolong the reexam? They did keep some of the new claims that they felt could be easily defended. IMHO

Opty

9
Sep 10, 2008 06:11AM
1
Sep 10, 2008 06:39AM
17
Sep 10, 2008 08:27AM
Share
New Message
Please login to post a reply